Closed
11.25 4.46
24h
Min
11.19
Max
11.46
Income | 1.9M -14M |
---|---|
Sales | -3.4M 15M |
EPS | -0.173 |
Profit margin | -88.244 |
Employees | 97 |
EBITDA | -7.5M -14M |
Recommendations | Buy |
---|---|
12 Months Forecast | +51.11% upside |
Next Earnings | 4 sie 2025 |
---|
Market Cap | 118M 558M |
---|---|
Previous open | 6.79 |
Previous close | 11.25 |
By Trading Central
Confidence
Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 17 USD 51.11%
High 24 USD
Low 12 USD
Based on 4 Wall Street analysts offering 12 month price targets forTheravance Biopharma Inc - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$